<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320872">
  <stage>Registered</stage>
  <submitdate>25/11/2009</submitdate>
  <approvaldate>30/11/2009</approvaldate>
  <actrnumber>ACTRN12609001031257</actrnumber>
  <trial_identification>
    <studytitle>Effects of azitromycin on Hospitalized Infants With Acute Bronchiolitis: A Randomized, prospective, double-blind, placebo-controlled study.</studytitle>
    <scientifictitle>Effects of azitromycin on length of hospital stay in Infants With Acute Bronchiolitis: A Randomized, prospective, double-blind, placebo-controlled study.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Acute Viral Bronchiolitis</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Azitromycin - oral syrup 
Dose 10mg/kg/day - oral 7 days</interventions>
    <comparator>Placebo, micro cellulose syrup, in the same amount that azitromycin (10mg/kg/day) - oral - 7 day</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction in the length of hospital stay (length of the hospital stay  or the time until the infant was ready for discharge according medical records).</outcome>
      <timepoint>Hours of hospital stay</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of need for supplemental oxygen, assessed by medical and nursing records.</outcome>
      <timepoint>Hours of supplemental oxygen</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Infants less than 7 months of age who were admitted to Hospital de Clínicas de Porto Alegre between March 2009 and July 2010 with a first episode of wheezing requiring hospitalization and supplemental oxygen, with a clinical diagnosis of bronchiolitis</inclusivecriteria>
    <inclusiveminage>10</inclusiveminage>
    <inclusiveminagetype>Days</inclusiveminagetype>
    <inclusivemaxage>7</inclusivemaxage>
    <inclusivemaxagetype>Months</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Infants with cardiac, metabolic disease or clinically significant respiratory disease, such as cystic fibrosis, were not eligible, although infants with chronic neonatal lung disease associated with prematurity were included. Infants were excluded if they had received corticosteroids in any form within 7days  before presentation or had received macrolides before presentation.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>After written informed parental consent had been obtained, the infants were randomly assigned to receive seven doses of azitromicin or placebo, after 12 hours after their admission to the hospital. Allocaction was concealed contacting the holder of the allocation schedule who was “off-site”</concealment>
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate>10/03/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>84</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Universidade Federal do Rio Grande do Sul</primarysponsorname>
    <primarysponsoraddress>Rua Ramiro Barcelos, 2400 
2nd Floor
Porto Alegre RS
Brazil
ZIP CODE= CEP 90035-003</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Hospital de Clinicas de Porto Alegre</fundingname>
      <fundingaddress>Ramiro Barcellos, 2350
Porto Alegre - RS
Brazil
ZIP CODE= CEP 90035-903</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is evaluate the efficacy of azitromycin (a drug) in infants less than 7 months of age with acute viral bronchiolitis, by reducing the length of hospital stay.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comite de Etica em Pesqquisa (CEP) - Grupo de Pesquisa e Pos Graduacao (GPPG)  Hospital de Clinicas de Porto Alegre</ethicname>
      <ethicaddress>Rua Ramiro Barcelos, 2350
Porto Alegre - RS - Brazil
ZIP CODE= CEP 90035-003</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Daniel Cardoso Barbosa</name>
      <address>Rua Ramiro Barcelos, 2350
Emergência Pediátrica
Porto Alegre - RS
Brazil 
ZIP CODE = CEP 90035-003</address>
      <phone>55 51 3359-8213</phone>
      <fax />
      <email>dcbarbosa@gmail.com</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Daniel Cardoso Barbosa</name>
      <address>Rua Ramiro Barcelos, 2350
Emergência Pediátrica
Porto Alegre - RS
Brazil 
ZIP CODE = CEP 90035-003</address>
      <phone>55 51 3359-8213</phone>
      <fax />
      <email>dcbarbosa@gmail.com</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Daniel Cardoso Barbosa</name>
      <address>Rua Ramiro Barcelos, 2350
Emergência Pediátrica
Porto Alegre - RS
Brazil 
ZIP CODE = CEP 90035-003</address>
      <phone />
      <fax />
      <email />
      <country>Brazil</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>